https://doi.org/10.4081/reumatismo.2012.7
MicroRNAs in autoimmune rheumatic diseases
Submitted: 18 October 2011
Accepted: 29 November 2011
Published: 16 March 2012
Accepted: 29 November 2011
Abstract Views: 822
PDF: 800
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The etiology of autoimmune diseases remains largely unknown. In recent years, besides genetic factors, several studies proposed that the epigenome may hold the key to a better understanding of autoimmunity initiation and perpetuation. More specifically epigenetic regulatory mechanisms comprise DNA methylation, a variety of histone modifications, and microRNA (miRNA) activity, all of which act upon gene and protein expression levels. In particular it is well known that epigenetic mechanisms are important for controlling the pattern of gene expression during development, the cell cycle, and the response to biological or environmental changes. In the present review a description of the most frequent epigenetic deregulations, in particular the role of miRNA, in rheumatic autoimmune disorders will be analyzed.
Supporting Agencies
FIRA (Fondazione Italiana per la Ricerca sull'Artrite)How to Cite
Galeazzi, M., Balistreri, E., Giannitti, C., & Sebastiani, G. (2012). MicroRNAs in autoimmune rheumatic diseases. Reumatismo, 64(1), 7–17. https://doi.org/10.4081/reumatismo.2012.7
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bagnato, G. Bianchi, M. Ceruso, G. A. Checchia, G. M. D'Avola, G. Di Giacinto, B. Frediani, A. Lombardi, A. Mannoni, G. Mascheroni, M. Matucci Cerinic, L. Punzi, P. Richelmi, M. Scarpellini, F. Torretta, A. Migliore, R. Ramonda, G. Minisola, Italian Society for Rheumatology recommendations for the management of hand osteoarthritis , Reumatismo: Vol. 65 No. 4 (2013)
- S. Vettori, G. Cuomo, G. Abignano, M. Iudici, G. Valentini, Survival and death causes in 251 systemic sclerosis patients from a single Italian center , Reumatismo: Vol. 62 No. 3 (2010)
- A. Volpe, A. Angheben, A. Marchetta, P. Caramaschi, D. Biasi, A. Carletto, S. Marocco, G. Monteiro, L.M. Bambara, G. Arcaro, Z. Bisoffi, Chikungunya arthritis: report of 6 cases , Reumatismo: Vol. 60 No. 2 (2008)
- S. Pirri, R. Talarico, D. Marinello, G. Turchetti, M. Mosca, A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools , Reumatismo: Vol. 73 No. 3 (2021)
- M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola, Italian Society of Rheumatology recommendations for the management of gout , Reumatismo: Vol. 65 No. 1 (2013)
- M. Amatruda, N.S. Carucci, C. Fede, G. Conti, Subclinical TRAPS treated with canakinumab , Reumatismo: Vol. 73 No. 2 (2021)
- A. Mahfoudh, K. Fennani, M. Akrout, K. Taoufik, Determinants of occupational multisite musculoskeletal disorders: a cross sectional study among 254 patients , Reumatismo: Vol. 70 No. 2 (2018)
- B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi, TNFα blockers and infectious risk in rheumatoid arthritis , Reumatismo: Vol. 61 No. 3 (2009)
- C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri, Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide , Reumatismo: Vol. 62 No. 3 (2010)
- E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado, Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study) , Reumatismo: Vol. 73 No. 3 (2021)
<< < 35 36 37 38 39 40 41 42 43 44 > >>
You may also start an advanced similarity search for this article.
